Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Summary for Patients    Summary for Patients (PDF)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Yan, A. T.    Liu, P. P.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials

Andrew T. Yan, MD; Raymond T. Yan, MD; and Peter P. Liu, MD

18 January 2005 | Volume 142 Issue 2 | Pages 132-145

Heart failure is an important cause of morbidity and mortality. Clinical trials over the past 2 decades have revolutionized the care of patients with systolic heart failure, and substantial data support the use of angiotensin-converting enzyme inhibitors, ß-blockers, angiotensin-receptor blockers, and aldosterone blockers in the management of this serious condition. This article reviews the evidence on the pharmacologic treatment of heart failure, with a focus on recent clinical trials.

Author and Article Information

From St. Michael's Hospital, the Heart & Stroke/Richard Lewar Centre of Excellence, and Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

Grant Support: In part by grants from the Heart and Stroke Foundation of Ontario and the Canadian Institutes of Health Research, Canadian Heart Failure Research Network, and Tailored Advanced Collaborative Training in Cardiovascular Science Partnership Programs of the Heart and Stroke Foundation and the Canadian Institutes of Health Research. Dr. Liu holds the Heart & Stroke/Polo Chair Professor of Medicine and Physiology at the University Health Network, University of Toronto. Dr. Andrew Yan is supported by Canadian Institutes of Health Research and Canadian Heart Research Centre Fellowship Awards.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Peter Liu, MD, Heart & Stroke/RL Centre of Excellence, NCSB 11-1266, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada; e-mail, peter.liu{at}utoronto.ca.

Current Author Addresses: Drs. A. Yan and R. Yan: Division of Cardiology, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada.

Dr. Liu: Heart & Stroke/RL Centre of Excellence, NCSB 11-1266, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada.

Related articles in Annals:

Summaries for Patients
Wide Range of Drugs Now Available To Effectively Treat Chronic Heart Failure

Annals 2005 142: I-53. [Full Text]  

This article has been cited by other articles:

				C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263. [Full Text] [PDF]

				C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): e714 - e833. [Full Text] [PDF]

				M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF]

				J. B. Young Whither Withering's Legacy?: Digoxin's Role in Our Contemporary Pharmacopeia for Heart Failure J. Am. Coll. Cardiol., August 2, 2005; 46(3): 505 - 507. [Full Text] [PDF]